HIV Lecture

31
A global view of HIV infection 38.6 million people [33.4  !46.0 million] living with HIV, 2008 The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the le again. If the red x still appears, you may have to delete the image and then insert it again. 2.4 The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the le again. If the red x still appears, you may have to delete the image and then insert it again. The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the le again. If the red x still appears, you may have to delete the image and then insert it again. About 1.1 million in the U.S. are HIV-positive! About 56,000 new HIV infections in the US per year! About one-quarter of infected people don t realize they are infecte !

Transcript of HIV Lecture

Page 1: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 1/31

A global view of HIV infection38.6 million people [33.4 !46.0 million] living with HIV, 2008

The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete theimage and then insert it again.

2.4

The image cannot be displayed. Your computermay not have enough memory to open theimage, or the image may have been corrupted.Restart your computer, and then open the fileagain. If the red x still appears, you may have todelete the image and then insert it again.

The image cannot be displayed. Your computer may not have enough memory to open theimage, or the image may have been corrupted. Restart your computer, and then open the fileagain. If the red x still appears, you may have to delete the image and then insert it again.

About 1.1 million in the U.S. are HIV-positive!About 56,000 new HIV infections in the US per year!About one-quarter of infected people don!t realize they are infecte !

Page 2: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 2/31

Page 3: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 3/31

How virus load and CD4 counts change over time

in a typical infection

1200

1000

800

600

400

200

0

0 3 6 9 12 1 2 3 4 5 6 7 8 9 10 11+

0

1/21/4

1/8

1/16

1/32

1/64

1/1281/256

1/512

   C   D   4   +    T

  -  c  e   l   l  s ,  c  e   l   l  s   /µ   L P 

l   a s

m aV i  r  emi   a (  Di  l   u t  i   on al  T i   t   er  )  

Clinical latency

Opportunisticdiseases

Constitutionalsymptoms

Death± Acute HIV syndromewide dissemination of virus

seeding of lymphoid organs

Primaryinfection

Weeks Years

Acute!

Phase! Clinical latency!

AIDS!

Page 4: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 4/31

HIV infected persons with CD4 < 200or

HIV-infected and have had an AIDS defining illness:Candidiasis of bronchi, trachea, or lungs ! ! !Candidiasis, esophageal!Cervical cancer, invasive ! ! ! !Encephalopathy, HIV-related!

Coccidioidomycosis, disseminated or extrapulmonary!Toxoplasmosis of brain

!

Cryptococcosis, extrapulmonary ! ! !Pneumonia, recurrent!Cryptosporidiosis, chronic intestinal (>1 month's duration) ! Lymphoma, primary, of brain!

Cytomegalovirus disease (other than liver, spleen, or nodes) !Wasting syndrome due to HIV!

Cytomegalovirus retinitis (with loss of vision)!Herpes simplex: chronic ulcers (>1 month's duration); or bronchitis, pneumonitis, or esophagitis!

Histoplasmosis, disseminated or extrapulmonary!

Isosporiasis, chronic intestinal (>1 month's duration)*Kaposi's sarcoma!

*Lymphoma, Burkitt's (or equivalent term)!

Lymphoma, immunoblastic (or equivalent term)!Mycobacterium avium complex or M. kansasii, disseminated or extrapulmonary!

Mycobacterium tuberculosis, any site (pulmonary** or extrapulmonary)!Mycobacterium, other species or unidentified species, disseminated or extrapulmonary!

Pneumocystis carinii pneumonia!

Progressive multifocal leukoencephalopathy!

Salmonella septicemia, recurrent!

Definition of AIDS:!

Page 5: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 5/31

Single stranded, RNA viral genome!

Double stranded, DNA copy!

Viral Reverse!

Transcriptase!

enzyme (RT for short)!

What makes retroviruses unique?!

Feature 1: Retroviruses make DNA out of RNA!

Why is this important?1. RT is a drug target!2. RT makes mistakes - high error rate gives rise to

drug resistance!

5!! 3!!

5!!

3!! 5!!

3!!

Page 6: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 6/31

Viral Integrase enzyme!

What makes retroviruses unique?Feature 2: Retroviruses integrate their DNA

into the host chromosome

Why is this important?1.Integrase is a drug target!

2.Once integrated, the viral DNA becomes a permanent part

of the cell - it can only be eradicated by killing the cell.

Makes HIV a life-long infection. But, good for gene therapy!

5!!

3!! 5!!

3!!Viral DNA!

Host cell DNA!

+!

Integrated viral DNA!

Page 7: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 7/31

Science, October 4, 2002!

Nature, October 10, 2002!

Page 8: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 8/31

Where does integration occur?!

Retroviruses preferentially integrate at active genes!

From: Schroder et al. Cell 110, 521-529; 2002!

Page 9: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 9/31

Page 10: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 10/31

Virus Strain E

Virus Strain C

Virus Strain D

Percent SequenceDivergence

46810 2 0

When and from where did HIV come from?!

Constructing a phylogenetic tree!

Virus Strain A

Virus Strain B

Page 11: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 11/31

!

Timing the origin of the HIV pandemic

A. Phylogenetic tree of env sequences obtained over past 20 yrs.!B. Branch lengths from each leaf to the root of the tree plotted

against time. Linear fit to the data is shown (bold turquoise line).!C. Enlarged version of inset in part B!!

HIV has evolved into multiple clades, or subtypes!

Common!

ancestor!

Page 12: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 12/31

HIV and SIV are closely related!

Virutally all old-world primates have their own strain of SIV!Infected animals don

!

t get sick - a perfect host-parasite relationshi!

Page 13: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 13/31

SIV Chimpanzee!

Strains!

SIV Sooty Mangabey!

Strains!

HIV-1!

HIV-2!

Relationships between HIV and SIV: HIV as a zoonosis

This genetic evidence argues thatHIV-1 arose from transmission ofSIV from chimpanzees to humans!

!

It also argues that HIV-2 arosefrom transmission of SIV from

sooty mangabeys to humans!

Page 14: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 14/31

RNAlater  

Non-Invasive SIVcpz Detection!

Slide from Beatrice Hahn, UAB!

Page 15: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 15/31

Extended Survey of Wild Apesin Cameroon

!

MB! LB!BB!EK!

DP!BQ!WE!

MT!DG!

CP!

TK!MG!MP!MF!

SL!BM!

NK!

KG!

* ! 

SIVcpzTAN3SIVcpzTAN2

SIVcpzTAN1

100

SIVcpzAnt

100

SIVcpzGAB2SIVcpzMT117

SIVcpzMT145

SIVcpzDP995

100

SIVcpzDP22SIVcpzDP23 SIVcpzDP24SIVcpzCAM155

100

SIVcpzCAM13SIVcpzGAB199

SIVcpzCAM3

SIVcpzDP933

SIVcpzDP942100SIVcpzCAM5

SIVcpzUS

SIVcpzEK505 SIVcpzEK502SIVcpzEK519

SIVcpzEK516SIVcpzBM1034 

100

100

91

98

97

94

SIVcpzMB189

SIVcpzMB802SIVcpzMB23

100

SIVcpzMB771SIVcpzMB803SIVcpzLB7

100

SIVcpzLB714SIVcpzLB715100

SIVcpzLB730SIVcpzMB317 

SIVcpzMB751

SIVcpzMB749100

SIVcpzMB248 

SIVcpzMB245SIVcpzMB66

99

SIVcpzMB897

100

99

6

96

100

0.05

HIV-1/N

HIV-1/N

HIV-1/MHIV-1/M

HIV-1/M

HIV-1/M

HIV-1/O

HIV-1/O

gp41!

Slide from Beatrice Hahn UAB

Page 16: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 16/31

a, Map of west-central Africa showing major rivers, and cities with explosive population growthin the twentieth century. Chimpanzees carrying the SIV strains most closely related to theviruses of HIV-1 group M, such as that described by Worobey et al.2, have been found insoutheast Cameroon (red ring). b, Léopoldville in 1896 (view from Mount Léopold) and c,around 1955 (the commercial centre).(Photos F. L. Michel (b) and C. Lamote (c), collection of

the Royal Museum for Central Africa, Tervuren, Belgium.)!

Sharp and Hahn, Nature 455:605 (2008)!

Page 17: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 17/31

HIV-1: A Class I Fusion System

Cryoelectron micrographsof virions with artificially

high numbers of spikes

Zanetti et al, PLoS Pathog. 2006

Reverse transcriptase (RT)!Protease!Integrase

!

HAART!

Perhaps only 10"

spike!

 trimers per virion

High cost

(getting better)

 Side-effects(getting better)

Difficult regimens(rapidly changing)

Multi-drug

resistant viruses(getting worse)

Page 18: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 18/31

Page 19: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 19/31

Selective Pressure of Therapy

   V   i  r  a   l   l  o  a   d

Time

Drug-susceptible quasispeciesDrug-resistant quasispecies

Page 20: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 20/31

Selective Pressure of TherapyTreatment begins

   V   i  r  a   l   l  o  a   d

Time

Drug-susceptible quasispeciesDrug-resistant quasispecies

Page 21: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 21/31

Selective Pressure of Therapy

Incomplete suppression

•" Inadequate potency

•" Inadequate drug levels

•" Inadequate adherence

•" Pre-existing resistance

   V   i  r  a   l   l  o  a   d

Time

Drug-susceptible quasispeciesDrug-resistant quasispecies

Treatment begins

Page 22: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 22/31

Genotypic analysis of plasma HIV from

patients on therapy with ritonavir 

Weeks

   P   l  a  s  m  a   R   N   A

   (   b   D   N   A   )

104

105

106

104

105

48444036322824201612840

104

105

V82V/A

V82V/A

WT

V82AI54VA71V

V82AI54VA71V

M36M/IK20K/R

V82AI54VA71VM36IK20R

V82AI54VA71VM36IK20R

Patient 235

Patient 203

WT

V82AI54VA71V

V82AI54VA71V

M46I/M

WT WT WT WT WT

Patient 124

600 mg bid

no drug

V82AI54I/V

A71A/V

600 mgBID

400 mg

BID

500 mg

BID

Molla, et al., Nature Medicine, 1996

Page 23: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 23/31

Protease inhibitors! RT Inhibitors (Nucs)!

RT and PI resistance is now well understood - viralgenotyping is highly predictive of phenotype

Dark: causes phenotypic resistance; Orange: contributes to resistance; Light Orange: accessory

resistance mutation; IS - increased susceptibility to drug.!

Page 24: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 24/31

H+

Endosome

Enveloped Virus Entry:1. !Attachment2. Receptor engagement

3. !Trigger Event! !pH-dependent! !pH-independent4. !Conformational Change5. !Membrane Fusion

Page 25: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 25/31

Page 26: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 26/31

Page 27: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 27/31

Page 28: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 28/31

2!1!

3!

Huang et al. Sci. 310:1025 (2005)!

Page 29: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 29/31

Coreceptor

Helical Region 1! Helical Region 2!

NH2!Fusion peptide!

T20!

Page 30: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 30/31

Provided by Trimeris, Inc.!

Page 31: HIV Lecture

8/3/2019 HIV Lecture

http://slidepdf.com/reader/full/hiv-lecture 31/31

Targets for HIV Entry Inhibitors

maraviroc (2007) enfuvirtide (2003)Licensed entry inhibitors: